China: Pharma Investigations Show New Trends In Commercial Bribery Enforcement

Last Updated: 3 July 2014
Article by Chris Chen, Richard Ma and Xing Wan

A number of recent commercial bribery cases concerning multinational pharmaceutical companies have drawn extensive attention. On 14 May 2014, the Chinese police published the results of their year-long investigation into commercial bribery allegations against GlaxoSmithKline, and reportedly have transferred the case to the prosecutor who will bring a criminal case against the company and certain individuals.
In related developments, the Hangzhou office of Swiss pharmaceutical company, Roche, was subject to an unannounced on-site inspection by the local AIC on 21 May 2014, and Eli Lilly, AstraZeneca and Novo Nordisk were named in a Hangzhou Health Bureau internal document for suspicion of commercial bribery. Taken together with the country's recent investigation into domestic pharmaceutical companies such as Sinopharm and Sanjing Pharmaceutical Co., Ltd., these cases show that the government is engaged in a sustained anti-commercial bribery drive focusing on the medical and pharmaceutical industry.

New Trends

A close look at key aspects of the current anti-bribery drive shows that this round of investigations exhibits characteristics distinct from previous anti-bribery campaigns, and its influence extends beyond the medical and pharmaceutical industry itself. We identify the key characteristics of the current anti-bribery drive below.

Shift of Focus from Bribe Receivers to Bribe Givers

In 2006, the Chinese government organized a joint action of some 20 ministries and commissions including the Supreme People's Court, the Ministry of Public Security and the Ministry of Health to specifically target bribe-taking hospitals and medical institutions.  Now, after years of anti-bribery practice, the Chinese government has realized the importance of punishing both the giving and receiving of commercial bribes, and is instead, in the current anti-bribery drive, focusing on investigating pharmaceutical companies that are typically in the position of offering bribes.

Increasing Regulatory Scrutiny of Multinationals

In recent years, regulation of, and law enforcement against, multinational companies by the Chinese government have become increasingly intensified. In addition to the companies caught up in this latest round of investigations, many other well-known multinational companies have been investigated in China in recent years on suspicion of commercial bribery, including Morgan Stanley, IBM, Lucent, Wal-Mart, DPC and Siemens.
In addition, in the GSK case, the Chinese government brought prosecution cases against GlaxoSmithKline China, its pharmaceutical subsidiaries and senior officers overseeing the company's China operations. The accused individuals include both Chinese nationals as well as foreign senior managers who voluntarily returned to China to assist with the investigation, which has been rare in previous cases. Video of the interview with a GlaxoSmithKline senior manager who admitted his guilt was broadcast on CCTV. This unusually publicized process demonstrates that the Chinese government is paying particular attention to multinational companies and is increasing scrutiny of multinationals in anti-commercial bribery actions.

Focus on Pricing and Other Business Fundamentals

During the current anti-bribery drive, the Chinese government is also focusing on what it sees as root causes of commercial bribery such as product pricing and "transfer pricing". In the GSK case, some reports have alleged that the prices of GlaxoSmithKline drugs in China were substantially higher than prices for the same drugs in other countries, and that GlaxoSmithKline's commercial bribery activities in China were made possible by the enormous profits generated through transfer pricing. According to these reports, GlaxoSmithKline allegedly increased the price of pharmaceutical products imported to China by way of internal transfer pricing, which elevated the apparent cost of sales in China without increasing the actual cost to the company. In 2013, in an inquiry into pharmaceutical product prices, the National Development and Reform Commission was reported to have made special on-site visits to investigate production costs and pricing mechanisms of dozens of domestic and foreign pharmaceutical companies. Further inquiries are expected to extend to fundamental business issues, such as product pricing, in connection with the commercial bribery investigations.

Our Advice

This latest round of anti-commercial bribery investigations shows that, as a result of increasing competition in the Chinese market, multinationals are facing a more strict and complicated regulatory and compliance environment in China, and must strive to comply with the regulatory requirements while remaining competitive in the market. Drawing on our extensive experience advising multinational companies operating in China, we believe that the following guidelines are the keys to establishing and operating an effective compliance system in China.

Establish China-specific Compliance Systems

The "localization" of multinationals' global compliance mechanisms is critical. The first and foremost step in localization is identifying targeted "red flags" that signal the most risky circumstances and require heightened attention. Common red flags for Chinese companies include giving excessive gifts, having luxury business meals/entertainment, hosting and sponsoring various types of expensive conferences, retaining advisors and agents designated by interested parties, or hiring employees recommended by interested parties, etc. In response to these red flags, multinationals may formulate tailor-made reporting, recording, approval, and reimbursement procedures to minimize the risk of non-compliance.

Strengthen the Training and Education of Employees

A robust compliance system depends on the understanding and implementation of employees. Therefore, it is essential to strengthen training and education programs to ensure that employees fully understand compliance requirements and are held responsible for effective execution. In addition, in China's pro-employee legal environment, an employer could easily find itself in a disadvantageous position if a dispute arises between the employer and its employees due to misunderstandings regarding the company's compliance requirements. An effective safeguard in this situation is to have a regular, thorough and vigorous compliance training program in place that defuses confusion and misunderstanding.

Closely Monitor Any Enforcement Trends

In our experience, enforcement actions by the Chinese government tend to come in waves, and government actions in a given period may share similar characteristics and exhibit certain trends in terms of enforcement focus and policy considerations. We believe it is important for multinational companies to closely monitor any enforcement trends and therefore benefit from the timely analysis of enforcement actions, recognition of the specific characteristics, and prompt adoption of preemptive measures to address any potential issues.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Mondaq Advice Centre (MACs)
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.